These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 8607184
21. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T, Lehmann M, Flye MW. Transplantation; 1997 Jan 27; 63(2):284-92. PubMed ID: 9020332 [Abstract] [Full Text] [Related]
22. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses. Bishop DK, Li W, Chan SY, Ensley RD, Shelby J, Eichwald EJ. Transplantation; 1994 Sep 15; 58(5):576-84. PubMed ID: 7522364 [Abstract] [Full Text] [Related]
24. MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host. Bumgardner GL, Gao D, Li J, Bickerstaff A, Orosz CG. Transplantation; 2002 Sep 27; 74(6):855-64. PubMed ID: 12364867 [Abstract] [Full Text] [Related]
25. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection. Pelletier R, Ohye R, Kincade P, Ferguson R, Orosz C. Transplant Proc; 1993 Feb 27; 25(1 Pt 1):839-41. PubMed ID: 7679845 [No Abstract] [Full Text] [Related]
26. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ. Transplantation; 1993 Oct 27; 56(4):892-7. PubMed ID: 8212213 [Abstract] [Full Text] [Related]
27. Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Sayegh MH, Sablinski T, Tanaka K, Kut JP, Kwok CA, Tilney NL, Kupiec-Weglinski JW, Milford EL. Transplantation; 1991 Feb 27; 51(2):296-9. PubMed ID: 1704648 [Abstract] [Full Text] [Related]
28. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Yin DP, Sankary HN, Talor-Edwards C, Chong AS, Foster P, Shen J, Ma LL, Williams JW, Fathman CG. Transplantation; 1998 Jul 15; 66(1):1-5. PubMed ID: 9679814 [Abstract] [Full Text] [Related]
29. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice. Mottram PL, Pietersz GA, Smyth MJ, Purcell LJ, Clunie GJ, McKenzie IF. Transplantation; 1993 Mar 15; 55(3):484-90. PubMed ID: 8456465 [Abstract] [Full Text] [Related]
30. Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model. Hirozane T, Matsumori A, Furukawa Y, Sasayama S. Circulation; 1995 Jan 15; 91(2):386-92. PubMed ID: 7805242 [Abstract] [Full Text] [Related]
31. An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine. Burkhardt K, Charlton B, Mandel TE. Transplantation; 1989 May 15; 47(5):771-5. PubMed ID: 2655212 [Abstract] [Full Text] [Related]
32. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A. Transplantation; 2002 Jun 15; 73(11):1736-42. PubMed ID: 12084995 [Abstract] [Full Text] [Related]
33. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW. Transplantation; 1999 Jul 27; 68(2):288-93. PubMed ID: 10440403 [Abstract] [Full Text] [Related]
34. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL. Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596 [Abstract] [Full Text] [Related]
35. The immunopharmacology of immunosuppression by 15-deoxyspergualin. Yuh DD, Morris RE. Transplantation; 1993 Mar 15; 55(3):578-91. PubMed ID: 7681226 [Abstract] [Full Text] [Related]
36. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model. Wang H, Hosiawa KA, Garcia B, Shum JB, Dutartre P, Kelvin DJ, Zhong R. Transplantation; 2003 May 15; 75(9):1475-81. PubMed ID: 12792500 [Abstract] [Full Text] [Related]
37. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice. Iida S, Omoto K, Kanemitsu I, Setoguchi K, Ishida H, Tanabe K, Suzuki T, Tashiro Y, Kishimoto H, Abe R. Exp Clin Transplant; 2012 Aug 15; 10(4):375-85. PubMed ID: 22758208 [Abstract] [Full Text] [Related]
38. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Pearson TC, Bushell AR, Darby CR, West LJ, Morris PJ, Wood KJ. Clin Exp Immunol; 1993 May 15; 92(2):211-7. PubMed ID: 8097975 [Abstract] [Full Text] [Related]
39. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Transplantation; 1993 May 15; 55(5):1112-8. PubMed ID: 8497891 [Abstract] [Full Text] [Related]